SC0062 Capsule

· Biocity Biopharmaceutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SC0062 Capsule, covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria [Phase 3]